XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | -26.76%2.71B | -26.76%2.71B | -9.93%2.97B | -21.98%2.73B | 39.31%4.15B | 97.29%3.7B | 97.29%3.7B | 161.37%3.3B | 250.49%3.5B | 74.92%2.98B |
-Cash and cash equivalents | -17.72%2.54B | -17.72%2.54B | -16.31%2.35B | -22.58%2.33B | 48.46%3.69B | 116.96%3.09B | 116.96%3.09B | 200.90%2.81B | 326.36%3.02B | 87.74%2.49B |
-Restricted cash and investments | -72.14%171.07M | -72.14%171.07M | 27.25%614.79M | -18.22%397.04M | -7.19%454.52M | 35.55%614.11M | 35.55%614.11M | 48.08%483.14M | 66.47%485.48M | 29.88%489.74M |
Receivables | ---- | ---- | ---- | ---- | ---- | 33.69%169.85M | 33.69%169.85M | ---- | ---- | ---- |
-Accounts receivable | ---- | ---- | ---- | ---- | ---- | 33.69%169.85M | 33.69%169.85M | ---- | ---- | ---- |
Prepaid assets | ---- | ---- | ---- | ---- | ---- | -29.16%52.02M | -29.16%52.02M | ---- | ---- | ---- |
Net loan | 19.91%27.53B | 19.91%27.53B | 24.65%26.62B | 36.09%25.26B | 43.34%23.2B | 65.59%22.96B | 65.59%22.96B | 90.60%21.36B | 126.01%18.56B | 124.12%16.19B |
-Gross loan | 19.82%27.58B | 19.82%27.58B | 24.57%26.67B | 36.07%25.31B | 43.31%23.25B | 65.49%23.01B | 65.49%23.01B | 90.47%21.41B | 125.88%18.6B | 124.11%16.23B |
-Allowance for loans and lease losses | -14.65%46.68M | -14.65%46.68M | -6.75%48.42M | 25.91%51.91M | 31.78%51.31M | 34.10%54.7M | 34.10%54.7M | 51.07%51.92M | 77.87%41.23M | 117.94%38.94M |
Securities and investments | 170.07%1.9B | 170.07%1.9B | 168.10%1.55B | 185.66%1.57B | 170.25%973.1M | 76.91%701.94M | 76.91%701.94M | 26.91%579.74M | 12.79%548.23M | -31.37%360.07M |
-Available for sale securities | -54.40%91.65M | -54.40%91.65M | -62.38%76.22M | -60.54%121.86M | -61.80%134.59M | -43.75%200.99M | -43.75%200.99M | -50.09%202.59M | -29.39%308.81M | -29.40%352.36M |
-Short term investments | 260.13%1.8B | 260.13%1.8B | 291.91%1.48B | 503.21%1.44B | 10,782.62%838.51M | 1,170.39%500.94M | 1,170.39%500.94M | 640.87%377.15M | 391.19%239.42M | -69.87%7.71M |
Long term equity investment | ---- | ---- | ---- | ---- | ---- | 0.42%22.92M | 0.42%22.92M | ---- | ---- | ---- |
Derivative assets | ---- | ---- | ---- | ---- | ---- | 218.17%110.12M | 218.17%110.12M | ---- | ---- | ---- |
Net PPE | 20.40%369.09M | 20.40%369.09M | 18.65%350.38M | 15.31%329.64M | 14.95%315.41M | 14.71%306.54M | 14.71%306.54M | 11.51%295.31M | 11.03%285.88M | 12.48%274.39M |
-Gross PPE | -23.29%369.09M | -23.29%369.09M | 18.65%350.38M | 15.31%329.64M | 14.95%315.41M | 30.80%481.14M | 30.80%481.14M | 11.51%295.31M | 11.03%285.88M | 12.48%274.39M |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -73.52%-174.6M | -73.52%-174.6M | ---- | ---- | ---- |
Goodwill and other intangible assets | 4.92%2.03B | 4.92%2.03B | 4.22%2B | -8.29%2.02B | -9.48%1.98B | -12.50%1.94B | -12.50%1.94B | -14.44%1.92B | -3.72%2.2B | -4.59%2.19B |
-Goodwill | 0.00%1.39B | 0.00%1.39B | 0.00%1.39B | -15.07%1.39B | -14.14%1.39B | -14.14%1.39B | -14.14%1.39B | -14.14%1.39B | 0.94%1.64B | 0.45%1.62B |
-Other intangible assets | 17.52%639.92M | 17.52%639.92M | 15.31%611.09M | 11.66%622.78M | 3.86%588.25M | -8.02%544.52M | -8.02%544.52M | -15.23%529.96M | -15.25%557.76M | -16.59%566.39M |
Other assets | 3,007.69%1.71B | 3,007.69%1.71B | 67.65%882.72M | 58.07%737.49M | 47.53%686.72M | -57.81%55.18M | -57.81%55.18M | 31.88%526.54M | 8.03%466.56M | 80.07%465.47M |
Total assets | 20.54%36.25B | 20.54%36.25B | 22.89%34.38B | 27.70%32.64B | 39.43%31.31B | 58.22%30.07B | 58.22%30.07B | 76.68%27.98B | 101.73%25.56B | 83.34%22.45B |
Liabilities | ||||||||||
Total deposits | 39.51%25.98B | 39.51%25.98B | 55.74%24.41B | 80.51%23B | 114.15%21.6B | 153.61%18.62B | 153.61%18.62B | 211.47%15.67B | 369.72%12.74B | 772.76%10.09B |
Payables | ---- | ---- | ---- | ---- | ---- | 10.61%159.92M | 10.61%159.92M | ---- | ---- | ---- |
-Accounts payable | ---- | ---- | ---- | ---- | ---- | 10.61%159.92M | 10.61%159.92M | ---- | ---- | ---- |
Current accrued expenses | ---- | ---- | ---- | ---- | ---- | 38.56%202.26M | 38.56%202.26M | ---- | ---- | ---- |
Current debt and capital lease obligation | ---- | ---- | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M |
-Current debt | ---- | ---- | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M | 0.00%486M |
Long term debt and capital lease obligation | -34.57%3.19B | -34.57%3.19B | -52.44%2.8B | -55.56%2.72B | -56.41%2.52B | -5.28%4.88B | -5.28%4.88B | 38.33%5.88B | 78.89%6.12B | 24.44%5.77B |
-Long term debt | -34.94%3.09B | -34.94%3.09B | -53.26%2.69B | -56.38%2.62B | -57.39%2.41B | -5.22%4.75B | -5.22%4.75B | 39.66%5.77B | 82.55%6.01B | 25.65%5.66B |
-Long term capital lease obligation | -20.06%97.39M | -20.06%97.39M | -10.88%101.03M | -12.52%100.8M | -8.13%105.56M | -7.32%121.82M | -7.32%121.82M | -6.87%113.36M | -12.53%115.22M | -15.49%114.9M |
Non current deferred liabilities | ---- | ---- | ---- | ---- | ---- | -30.92%45.95M | -30.92%45.95M | ---- | ---- | ---- |
Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | 1,065.37%107.81M | 1,065.37%107.81M | ---- | ---- | ---- |
Other liabilities | 2,597.36%556.92M | 2,597.36%556.92M | 0.45%569.02M | -15.35%535.37M | 0.01%554.19M | -84.84%20.65M | -84.84%20.65M | 0.10%566.48M | 16.62%632.46M | 26.71%554.11M |
Total liabilities | 21.23%29.73B | 21.23%29.73B | 25.02%28.26B | 33.81%26.74B | 48.89%25.16B | 81.91%24.52B | 81.91%24.52B | 118.74%22.6B | 178.93%19.98B | 151.62%16.9B |
Shareholders'equity | ||||||||||
Share capital | -99.97%109K | -99.97%109K | -99.97%108K | -99.97%106K | 0.00%320.48M | 0.00%320.47M | 0.00%320.47M | 0.00%320.47M | 0.00%320.47M | 0.00%320.47M |
-common stock | 12.37%109K | 12.37%109K | 13.68%108K | 12.77%106K | 11.70%105K | 4.30%97K | 4.30%97K | 3.26%95K | 2.17%94K | 3.30%94K |
-Preferred stock | --0 | --0 | --0 | --0 | 0.00%320.37M | 0.00%320.37M | 0.00%320.37M | 0.00%320.37M | 0.00%320.37M | 0.00%320.37M |
Paid-in capital | 11.35%7.84B | 11.35%7.84B | 12.26%7.75B | 11.00%7.6B | 11.29%7.54B | 4.76%7.04B | 4.76%7.04B | 3.77%6.9B | 4.02%6.85B | 4.13%6.78B |
Retained earnings | 27.64%-1.31B | 27.64%-1.31B | 11.56%-1.64B | -7.15%-1.7B | -11.59%-1.72B | -20.00%-1.8B | -20.00%-1.8B | -26.56%-1.85B | -14.12%-1.59B | -18.90%-1.54B |
Gains losses not affecting retained earnings | -591.89%-8.37M | -591.89%-8.37M | 1,251.50%8.11M | 71.03%-1.48M | 67.07%-2.09M | 85.43%-1.21M | 85.43%-1.21M | 106.25%600K | 36.10%-5.12M | -6.32%-6.34M |
Total stockholders'equity | 17.46%6.53B | 17.46%6.53B | 13.91%6.12B | 5.80%5.9B | 10.65%6.15B | 0.48%5.55B | 0.48%5.55B | -2.32%5.37B | 1.30%5.58B | 0.43%5.55B |
Total equity | 17.46%6.53B | 17.46%6.53B | 13.91%6.12B | 5.80%5.9B | 10.65%6.15B | 0.48%5.55B | 0.48%5.55B | -2.32%5.37B | 1.30%5.58B | 0.43%5.55B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |